Predictors of effectiveness of glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes and obesity

Background: Type 2 diabetes mellitus (DM2), which mainly develops from visceral obesity, is a socially significant disease. Reduction of losses from DM2 is a priority in modern medicine development. Glucagon-like peptide-1 receptor agonists (aGLP-1) present one of few groups of antidiabetic drugs th...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Ekaterina V. Tikhonenko, Alina Y. Babenko, Evgeny V. Shlyakhto
Format: Artigo
Jezik:Inglês
Izdano: Endocrinology Research Centre 2018-12-01
Serija:Ожирение и метаболизм
Teme:
diabetes type 2
obesity
glucagon-like peptide-1 receptor agonists
glucagon-like peptide-1
ghrelin
food behavior
Online pristup:https://www.omet-endojournals.ru/jour/article/view/9584
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items